aluates Reports

$ 0.0

Automative

Global Inherited Metabolic Disorder Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-1S13660

Global Inherited Metabolic Disorder Market Research Report 2023

BUY CHAPTERS

Global Inherited Metabolic Disorder Market Research Report 2025

Code: QYRE-Auto-1S13660

Report

May 2025

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott (U.S.)

Admera Health

Promega Corporation

Alomone Labs

Bio Rad Laboratories

Novartis

Astareal AB

Regeneron Pharmaceuticals

Biophytis

AbbVie

Danone

Pfizer Inc

Bristol–Myers Squibb

Biogen

GSK

Roche Holding AG

Angeion Corporation

Mayo Clinic

Inherited Metabolic Disorder Market Size

The global market for Inherited Metabolic Disorder was valued at US$ 1463 million in the year 2024 and is projected to reach a revised size of US$ 2420 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Inherited Metabolic Disorder Market

Inherited metabolic disorders (IMDs) are a group of genetic conditions that affect the body’s ability to metabolize certain substances, such as proteins, carbohydrates, or fats. These disorders are typically caused by mutations in specific genes that affect enzymes or transport proteins crucial for normal metabolism.

The global inherited metabolic disorder market refers to the market for diagnostic tests, treatments, therapies, and related products and services for various inherited metabolic disorders. This market encompasses a wide range of disorders, each with its diagnostic and treatment requirements. Here are some key points regarding the global inherited metabolic disorder market:

Market Growth: The market for inherited metabolic disorders has been experiencing steady growth due to various factors. Technological advancements in diagnostics, increased awareness, and better access to healthcare services in developing countries contribute to market expansion.

Prevalence: Inherited metabolic disorders are relatively rare, but collectively, they affect a significant number of individuals worldwide. Certain disorders may be more prevalent in specific populations or regions. Newborn screening programs have helped in early detection, leading to increased prevalence rates.

Diagnostic Tests: The market for diagnostic tests, including genetic testing, biochemical testing, and newborn screening, plays a vital role in identifying inherited metabolic disorders. Improvements in diagnostic techniques, such as next-generation sequencing, have enabled more accurate and rapid detection of these disorders.

Therapeutic Approaches: Treatment options for inherited metabolic disorders depend on the specific disorder and its severity. Therapies may include enzyme replacement therapy, substrate reduction therapy, gene therapy, and small molecule therapies. Research and development efforts are ongoing to explore novel treatments for these disorders.

Orphan Drugs: Many inherited metabolic disorders are classified as rare diseases or orphan diseases. This designation provides companies with incentives to develop treatments through programs like orphan drug designation and market exclusivity. These incentives have spurred investment in research and development for orphan drugs targeting inherited metabolic disorders.

Challenges: The market for inherited metabolic disorders faces challenges such as high treatment costs, limited awareness among healthcare professionals and the general population, and limited accessibility to specialized treatments in certain regions.

This report aims to provide a comprehensive presentation of the global market for Inherited Metabolic Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inherited Metabolic Disorder.

The Inherited Metabolic Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inherited Metabolic Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inherited Metabolic Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Inherited Metabolic Disorder Market Report

Report Metric	Details
Report Name	Inherited Metabolic Disorder Market
Accounted market size in year	US$ 1463 million
Forecasted market size in 2031	US$ 2420 million
CAGR	7.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Enzyme Replacement Therapy Cellular Transplantation Small Molecule Based Therapy Substrate Reduction Therapy Gene Therapy Drug Therapy Others
Segment by Application	Hurler Syndrome Niemann-Pick Disease Tay-Sachs Disease Gaucher Disease Fabry Disease Krabbe Disease Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mayo Clinic, Angeion Corporation, Abbott U.S., Admera Health, Promega Corporation, Alomone Labs, Bio-Rad Laboratories, Novartis AG, AstaReal, Regeneron Pharmaceuticals, Biophytis, AbbVie, Danone, Pfizer, Bristol Myers Squibb, Biogen, GSK plc, Roche Holding AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inherited Metabolic Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Inherited Metabolic Disorder Market growing?

Ans: The Inherited Metabolic Disorder Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Inherited Metabolic Disorder Market size in 2031?

Ans: The Inherited Metabolic Disorder Market size in 2031 will be US$ 2420 million.

Who are the main players in the Inherited Metabolic Disorder Market report?

Ans: The main players in the Inherited Metabolic Disorder Market are Mayo Clinic, Angeion Corporation, Abbott U.S., Admera Health, Promega Corporation, Alomone Labs, Bio-Rad Laboratories, Novartis AG, AstaReal, Regeneron Pharmaceuticals, Biophytis, AbbVie, Danone, Pfizer, Bristol Myers Squibb, Biogen, GSK plc, Roche Holding AG

What are the Application segmentation covered in the Inherited Metabolic Disorder Market report?

Ans: The Applications covered in the Inherited Metabolic Disorder Market report are Hurler Syndrome, Niemann-Pick Disease, Tay-Sachs Disease, Gaucher Disease, Fabry Disease, Krabbe Disease, Others

What are the Type segmentation covered in the Inherited Metabolic Disorder Market report?

Ans: The Types covered in the Inherited Metabolic Disorder Market report are Enzyme Replacement Therapy, Cellular Transplantation, Small Molecule Based Therapy, Substrate Reduction Therapy, Gene Therapy, Drug Therapy, Others

Recommended Reports

Metabolic Disorders

Inherited & Genetic

Rare Disease Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Inherited Metabolic Disorder Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Enzyme Replacement Therapy

1.2.3 Cellular Transplantation

1.2.4 Small Molecule Based Therapy

1.2.5 Substrate Reduction Therapy

1.2.6 Gene Therapy

1.2.7 Drug Therapy

1.2.8 Others

1.3 Market by Application

1.3.1 Global Inherited Metabolic Disorder Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hurler Syndrome

1.3.3 Niemann-Pick Disease

1.3.4 Tay-Sachs Disease

1.3.5 Gaucher Disease

1.3.6 Fabry Disease

1.3.7 Krabbe Disease

1.3.8 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Inherited Metabolic Disorder Market Perspective (2020-2031)

2.2 Global Inherited Metabolic Disorder Growth Trends by Region

2.2.1 Global Inherited Metabolic Disorder Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Inherited Metabolic Disorder Historic Market Size by Region (2020-2025)

2.2.3 Inherited Metabolic Disorder Forecasted Market Size by Region (2026-2031)

2.3 Inherited Metabolic Disorder Market Dynamics

2.3.1 Inherited Metabolic Disorder Industry Trends

2.3.2 Inherited Metabolic Disorder Market Drivers

2.3.3 Inherited Metabolic Disorder Market Challenges

2.3.4 Inherited Metabolic Disorder Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Inherited Metabolic Disorder Players by Revenue

3.1.1 Global Top Inherited Metabolic Disorder Players by Revenue (2020-2025)

3.1.2 Global Inherited Metabolic Disorder Revenue Market Share by Players (2020-2025)

3.2 Global Inherited Metabolic Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Inherited Metabolic Disorder Revenue

3.4 Global Inherited Metabolic Disorder Market Concentration Ratio

3.4.1 Global Inherited Metabolic Disorder Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Inherited Metabolic Disorder Revenue in 2024

3.5 Global Key Players of Inherited Metabolic Disorder Head office and Area Served

3.6 Global Key Players of Inherited Metabolic Disorder, Product and Application

3.7 Global Key Players of Inherited Metabolic Disorder, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Inherited Metabolic Disorder Breakdown Data by Type

4.1 Global Inherited Metabolic Disorder Historic Market Size by Type (2020-2025)

4.2 Global Inherited Metabolic Disorder Forecasted Market Size by Type (2026-2031)

5 Inherited Metabolic Disorder Breakdown Data by Application

5.1 Global Inherited Metabolic Disorder Historic Market Size by Application (2020-2025)

5.2 Global Inherited Metabolic Disorder Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Inherited Metabolic Disorder Market Size (2020-2031)

6.2 North America Inherited Metabolic Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Inherited Metabolic Disorder Market Size by Country (2020-2025)

6.4 North America Inherited Metabolic Disorder Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Inherited Metabolic Disorder Market Size (2020-2031)

7.2 Europe Inherited Metabolic Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Inherited Metabolic Disorder Market Size by Country (2020-2025)

7.4 Europe Inherited Metabolic Disorder Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Inherited Metabolic Disorder Market Size (2020-2031)

8.2 Asia-Pacific Inherited Metabolic Disorder Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Inherited Metabolic Disorder Market Size by Region (2020-2025)

8.4 Asia-Pacific Inherited Metabolic Disorder Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Inherited Metabolic Disorder Market Size (2020-2031)

9.2 Latin America Inherited Metabolic Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Inherited Metabolic Disorder Market Size by Country (2020-2025)

9.4 Latin America Inherited Metabolic Disorder Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Inherited Metabolic Disorder Market Size (2020-2031)

10.2 Middle East & Africa Inherited Metabolic Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Inherited Metabolic Disorder Market Size by Country (2020-2025)

10.4 Middle East & Africa Inherited Metabolic Disorder Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Mayo Clinic

11.1.1 Mayo Clinic Company Details

11.1.2 Mayo Clinic Business Overview

11.1.3 Mayo Clinic Inherited Metabolic Disorder Introduction

11.1.4 Mayo Clinic Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.1.5 Mayo Clinic Recent Development

11.2 Angeion Corporation

11.2.1 Angeion Corporation Company Details

11.2.2 Angeion Corporation Business Overview

11.2.3 Angeion Corporation Inherited Metabolic Disorder Introduction

11.2.4 Angeion Corporation Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.2.5 Angeion Corporation Recent Development

11.3 Abbott U.S.

11.3.1 Abbott U.S. Company Details

11.3.2 Abbott U.S. Business Overview

11.3.3 Abbott U.S. Inherited Metabolic Disorder Introduction

11.3.4 Abbott U.S. Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.3.5 Abbott U.S. Recent Development

11.4 Admera Health

11.4.1 Admera Health Company Details

11.4.2 Admera Health Business Overview

11.4.3 Admera Health Inherited Metabolic Disorder Introduction

11.4.4 Admera Health Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.4.5 Admera Health Recent Development

11.5 Promega Corporation

11.5.1 Promega Corporation Company Details

11.5.2 Promega Corporation Business Overview

11.5.3 Promega Corporation Inherited Metabolic Disorder Introduction

11.5.4 Promega Corporation Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.5.5 Promega Corporation Recent Development

11.6 Alomone Labs

11.6.1 Alomone Labs Company Details

11.6.2 Alomone Labs Business Overview

11.6.3 Alomone Labs Inherited Metabolic Disorder Introduction

11.6.4 Alomone Labs Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.6.5 Alomone Labs Recent Development

11.7 Bio-Rad Laboratories

11.7.1 Bio-Rad Laboratories Company Details

11.7.2 Bio-Rad Laboratories Business Overview

11.7.3 Bio-Rad Laboratories Inherited Metabolic Disorder Introduction

11.7.4 Bio-Rad Laboratories Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.7.5 Bio-Rad Laboratories Recent Development

11.8 Novartis AG

11.8.1 Novartis AG Company Details

11.8.2 Novartis AG Business Overview

11.8.3 Novartis AG Inherited Metabolic Disorder Introduction

11.8.4 Novartis AG Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.8.5 Novartis AG Recent Development

11.9 AstaReal

11.9.1 AstaReal Company Details

11.9.2 AstaReal Business Overview

11.9.3 AstaReal Inherited Metabolic Disorder Introduction

11.9.4 AstaReal Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.9.5 AstaReal Recent Development

11.10 Regeneron Pharmaceuticals

11.10.1 Regeneron Pharmaceuticals Company Details

11.10.2 Regeneron Pharmaceuticals Business Overview

11.10.3 Regeneron Pharmaceuticals Inherited Metabolic Disorder Introduction

11.10.4 Regeneron Pharmaceuticals Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.10.5 Regeneron Pharmaceuticals Recent Development

11.11 Biophytis

11.11.1 Biophytis Company Details

11.11.2 Biophytis Business Overview

11.11.3 Biophytis Inherited Metabolic Disorder Introduction

11.11.4 Biophytis Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.11.5 Biophytis Recent Development

11.12 AbbVie

11.12.1 AbbVie Company Details

11.12.2 AbbVie Business Overview

11.12.3 AbbVie Inherited Metabolic Disorder Introduction

11.12.4 AbbVie Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.12.5 AbbVie Recent Development

11.13 Danone

11.13.1 Danone Company Details

11.13.2 Danone Business Overview

11.13.3 Danone Inherited Metabolic Disorder Introduction

11.13.4 Danone Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.13.5 Danone Recent Development

11.14 Pfizer

11.14.1 Pfizer Company Details

11.14.2 Pfizer Business Overview

11.14.3 Pfizer Inherited Metabolic Disorder Introduction

11.14.4 Pfizer Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.14.5 Pfizer Recent Development

11.15 Bristol Myers Squibb

11.15.1 Bristol Myers Squibb Company Details

11.15.2 Bristol Myers Squibb Business Overview

11.15.3 Bristol Myers Squibb Inherited Metabolic Disorder Introduction

11.15.4 Bristol Myers Squibb Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.15.5 Bristol Myers Squibb Recent Development

11.16 Biogen

11.16.1 Biogen Company Details

11.16.2 Biogen Business Overview

11.16.3 Biogen Inherited Metabolic Disorder Introduction

11.16.4 Biogen Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.16.5 Biogen Recent Development

11.17 GSK plc

11.17.1 GSK plc Company Details

11.17.2 GSK plc Business Overview

11.17.3 GSK plc Inherited Metabolic Disorder Introduction

11.17.4 GSK plc Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.17.5 GSK plc Recent Development

11.18 Roche Holding AG

11.18.1 Roche Holding AG Company Details

11.18.2 Roche Holding AG Business Overview

11.18.3 Roche Holding AG Inherited Metabolic Disorder Introduction

11.18.4 Roche Holding AG Revenue in Inherited Metabolic Disorder Business (2020-2025)

11.18.5 Roche Holding AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott (U.S.)

Admera Health

Promega Corporation

Alomone Labs

Bio Rad Laboratories

Novartis

Astareal AB

Regeneron Pharmaceuticals

Biophytis

AbbVie

Danone

Pfizer Inc

Bristol–Myers Squibb

Biogen

GSK

Roche Holding AG

Angeion Corporation

Mayo Clinic

List of Tables

Table 1. Global Inherited Metabolic Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Enzyme Replacement Therapy

Table 3. Key Players of Cellular Transplantation

Table 4. Key Players of Small Molecule Based Therapy

Table 5. Key Players of Substrate Reduction Therapy

Table 6. Key Players of Gene Therapy

Table 7. Key Players of Drug Therapy

Table 8. Key Players of Others

Table 9. Global Inherited Metabolic Disorder Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Inherited Metabolic Disorder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Inherited Metabolic Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Inherited Metabolic Disorder Market Share by Region (2020-2025)

Table 13. Global Inherited Metabolic Disorder Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Inherited Metabolic Disorder Market Share by Region (2026-2031)

Table 15. Inherited Metabolic Disorder Market Trends

Table 16. Inherited Metabolic Disorder Market Drivers

Table 17. Inherited Metabolic Disorder Market Challenges

Table 18. Inherited Metabolic Disorder Market Restraints

Table 19. Global Inherited Metabolic Disorder Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Inherited Metabolic Disorder Market Share by Players (2020-2025)

Table 21. Global Top Inherited Metabolic Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Metabolic Disorder as of 2024)

Table 22. Ranking of Global Top Inherited Metabolic Disorder Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Inherited Metabolic Disorder Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Inherited Metabolic Disorder, Headquarters and Area Served

Table 25. Global Key Players of Inherited Metabolic Disorder, Product and Application

Table 26. Global Key Players of Inherited Metabolic Disorder, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Inherited Metabolic Disorder Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Inherited Metabolic Disorder Revenue Market Share by Type (2020-2025)

Table 30. Global Inherited Metabolic Disorder Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Inherited Metabolic Disorder Revenue Market Share by Type (2026-2031)

Table 32. Global Inherited Metabolic Disorder Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Inherited Metabolic Disorder Revenue Market Share by Application (2020-2025)

Table 34. Global Inherited Metabolic Disorder Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Inherited Metabolic Disorder Revenue Market Share by Application (2026-2031)

Table 36. North America Inherited Metabolic Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Inherited Metabolic Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Inherited Metabolic Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Inherited Metabolic Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Inherited Metabolic Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Inherited Metabolic Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Inherited Metabolic Disorder Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Inherited Metabolic Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Inherited Metabolic Disorder Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Inherited Metabolic Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Inherited Metabolic Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Inherited Metabolic Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Inherited Metabolic Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Inherited Metabolic Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Inherited Metabolic Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 51. Mayo Clinic Company Details

Table 52. Mayo Clinic Business Overview

Table 53. Mayo Clinic Inherited Metabolic Disorder Product

Table 54. Mayo Clinic Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 55. Mayo Clinic Recent Development

Table 56. Angeion Corporation Company Details

Table 57. Angeion Corporation Business Overview

Table 58. Angeion Corporation Inherited Metabolic Disorder Product

Table 59. Angeion Corporation Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 60. Angeion Corporation Recent Development

Table 61. Abbott U.S. Company Details

Table 62. Abbott U.S. Business Overview

Table 63. Abbott U.S. Inherited Metabolic Disorder Product

Table 64. Abbott U.S. Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 65. Abbott U.S. Recent Development

Table 66. Admera Health Company Details

Table 67. Admera Health Business Overview

Table 68. Admera Health Inherited Metabolic Disorder Product

Table 69. Admera Health Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 70. Admera Health Recent Development

Table 71. Promega Corporation Company Details

Table 72. Promega Corporation Business Overview

Table 73. Promega Corporation Inherited Metabolic Disorder Product

Table 74. Promega Corporation Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 75. Promega Corporation Recent Development

Table 76. Alomone Labs Company Details

Table 77. Alomone Labs Business Overview

Table 78. Alomone Labs Inherited Metabolic Disorder Product

Table 79. Alomone Labs Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 80. Alomone Labs Recent Development

Table 81. Bio-Rad Laboratories Company Details

Table 82. Bio-Rad Laboratories Business Overview

Table 83. Bio-Rad Laboratories Inherited Metabolic Disorder Product

Table 84. Bio-Rad Laboratories Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 85. Bio-Rad Laboratories Recent Development

Table 86. Novartis AG Company Details

Table 87. Novartis AG Business Overview

Table 88. Novartis AG Inherited Metabolic Disorder Product

Table 89. Novartis AG Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 90. Novartis AG Recent Development

Table 91. AstaReal Company Details

Table 92. AstaReal Business Overview

Table 93. AstaReal Inherited Metabolic Disorder Product

Table 94. AstaReal Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 95. AstaReal Recent Development

Table 96. Regeneron Pharmaceuticals Company Details

Table 97. Regeneron Pharmaceuticals Business Overview

Table 98. Regeneron Pharmaceuticals Inherited Metabolic Disorder Product

Table 99. Regeneron Pharmaceuticals Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 100. Regeneron Pharmaceuticals Recent Development

Table 101. Biophytis Company Details

Table 102. Biophytis Business Overview

Table 103. Biophytis Inherited Metabolic Disorder Product

Table 104. Biophytis Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 105. Biophytis Recent Development

Table 106. AbbVie Company Details

Table 107. AbbVie Business Overview

Table 108. AbbVie Inherited Metabolic Disorder Product

Table 109. AbbVie Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 110. AbbVie Recent Development

Table 111. Danone Company Details

Table 112. Danone Business Overview

Table 113. Danone Inherited Metabolic Disorder Product

Table 114. Danone Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 115. Danone Recent Development

Table 116. Pfizer Company Details

Table 117. Pfizer Business Overview

Table 118. Pfizer Inherited Metabolic Disorder Product

Table 119. Pfizer Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 120. Pfizer Recent Development

Table 121. Bristol Myers Squibb Company Details

Table 122. Bristol Myers Squibb Business Overview

Table 123. Bristol Myers Squibb Inherited Metabolic Disorder Product

Table 124. Bristol Myers Squibb Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 125. Bristol Myers Squibb Recent Development

Table 126. Biogen Company Details

Table 127. Biogen Business Overview

Table 128. Biogen Inherited Metabolic Disorder Product

Table 129. Biogen Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 130. Biogen Recent Development

Table 131. GSK plc Company Details

Table 132. GSK plc Business Overview

Table 133. GSK plc Inherited Metabolic Disorder Product

Table 134. GSK plc Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 135. GSK plc Recent Development

Table 136. Roche Holding AG Company Details

Table 137. Roche Holding AG Business Overview

Table 138. Roche Holding AG Inherited Metabolic Disorder Product

Table 139. Roche Holding AG Revenue in Inherited Metabolic Disorder Business (2020-2025) & (US$ Million)

Table 140. Roche Holding AG Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

Table 144. Authors List of This Report

List of Figures

Figure 1. Inherited Metabolic Disorder Picture

Figure 2. Global Inherited Metabolic Disorder Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Inherited Metabolic Disorder Market Share by Type: 2024 VS 2031

Figure 4. Enzyme Replacement Therapy Features

Figure 5. Cellular Transplantation Features

Figure 6. Small Molecule Based Therapy Features

Figure 7. Substrate Reduction Therapy Features

Figure 8. Gene Therapy Features

Figure 9. Drug Therapy Features

Figure 10. Others Features

Figure 11. Global Inherited Metabolic Disorder Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Inherited Metabolic Disorder Market Share by Application: 2024 VS 2031

Figure 13. Hurler Syndrome Case Studies

Figure 14. Niemann-Pick Disease Case Studies

Figure 15. Tay-Sachs Disease Case Studies

Figure 16. Gaucher Disease Case Studies

Figure 17. Fabry Disease Case Studies

Figure 18. Krabbe Disease Case Studies

Figure 19. Others Case Studies

Figure 20. Inherited Metabolic Disorder Report Years Considered

Figure 21. Global Inherited Metabolic Disorder Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 22. Global Inherited Metabolic Disorder Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 23. Global Inherited Metabolic Disorder Market Share by Region: 2024 VS 2031

Figure 24. Global Inherited Metabolic Disorder Market Share by Players in 2024

Figure 25. Global Top Inherited Metabolic Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Metabolic Disorder as of 2024)

Figure 26. The Top 10 and 5 Players Market Share by Inherited Metabolic Disorder Revenue in 2024

Figure 27. North America Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. North America Inherited Metabolic Disorder Market Share by Country (2020-2031)

Figure 29. United States Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Canada Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Inherited Metabolic Disorder Market Share by Country (2020-2031)

Figure 33. Germany Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. France Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. U.K. Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Italy Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Russia Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Nordic Countries Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Inherited Metabolic Disorder Market Share by Region (2020-2031)

Figure 41. China Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Japan Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. South Korea Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. India Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Australia Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Inherited Metabolic Disorder Market Share by Country (2020-2031)

Figure 49. Mexico Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Brazil Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Inherited Metabolic Disorder Market Share by Country (2020-2031)

Figure 53. Turkey Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. UAE Inherited Metabolic Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Mayo Clinic Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 57. Angeion Corporation Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 58. Abbott U.S. Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 59. Admera Health Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 60. Promega Corporation Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 61. Alomone Labs Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 63. Novartis AG Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 64. AstaReal Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 65. Regeneron Pharmaceuticals Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 66. Biophytis Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 67. AbbVie Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 68. Danone Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 69. Pfizer Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 70. Bristol Myers Squibb Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 71. Biogen Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 72. GSK plc Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 73. Roche Holding AG Revenue Growth Rate in Inherited Metabolic Disorder Business (2020-2025)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Medical Foods for Inborn Errors of Metabolism Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Based Metabolic Disorders Therapeutics Market Research Report 2024

Gaucher Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurometabolic Disorders Market Insights Forecast to 2030

Metabolic Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sphingolipidoses Treatment Market Research Report 2025

Metabolic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs for Treating Metabolic Disorders Market Research Report 2024

Gaucher Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Metabolic Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adrenoleukodystrophy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gaucher Disease GD Drugs Market Insights Forecast to 2030

Global Metabolic Disease Therapeutics Market Research Report 2025

Global N Acetylglutamate Synthetase Deficiency NAGSD Market Research Report 2024

Global Metabolic Disease Drugs Market Research Report 2025

Mitochondrial Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adenosine Deaminase Deficiency Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Thalassemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Metabolic Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions